Differential gene expression of the neural cell adhesion molecule (N-CAM) in a panel of multiple myeloma cell lines

Leukemia

Volumn 12, Issue 1, 1998, Pages 86-93

  De Greef, C ^a   Van Riet, I ^a   Bakkus, M H C ^a   Van Camp, B ^a  

^a FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

CD56; Cell lines; Gene regulation; Multiple myeloma; N CAM

Indexed keywords

CD56 ANTIGEN; MESSENGER RNA; NERVE CELL ADHESION MOLECULE;

ARTICLE; CELL LINE; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENETIC ORGANIZATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; PLASMA CELL; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0031983341     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400897     Document Type: Article

References (44)

1. Edelman GM. Cell adhesion molecules in the regulation of animal form and tissue pattern. Annu Rev Cell Biol 1986; 2: 81-116.
2. Lanier LL, Testi R, Bindl J, Phillips JM. Identity of Leu19 (CD56) leucocyte differentiation antigen and neural cell adhesion molecule. J Exp Med 1989; 169: 2233-2238.
3. Van Camp B, Durie BGM, Spier C, De Waele M, Van Riet I, Vela E, Frutiger Y, Richter L, Grogan TM. Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19). Blood 1990; 76: 377-382.
4. Van Riet I, De Waele M, Remels L, Lacor P, Schots R, Van Camp B. Expression of cytoadhesion molecules (CD56, CD54, CD18 and CD29) by myeloma plasma cells. Br J Haematol 1991; 79: 421-427.
5. Kaiser U, Auerbach B, Oldenburg M. The neural cell adhesion molecule NCAM in multiple myeloma. Leuk Lymphoma 1996; 20: 389-395.
6. Frost G, Patel K, Bourne S, Coakham HB, Kemshead JT. Expression of alternative isoforms of the neural cell adhesion molecule (NCAM) on normal brain and a variety of brain tumors. Neuropathol Appl Neurobiol 1991; 17: 207-217.
7. Mechtersheimer G, Staudter M, Moller P. Expression of the natural killer cell-associated antigens CD56 and CD57 in human neural and striated muscle cells and in their tumors. Cancer Res 1991; 51: 1300-1307.
8. Thomas X, Vila L, Campos L, Sabido O, Archimbaud E. Expression of N-CAM (CD56) on acute leukemia cells: relationships with disease characteristics and outcome. Leuk Lymphoma 1995; 19: 295-300.
9. Seymour JF, Pierce SA, Kantarjian HM, Keating MJ, Estey EH. Investigation of karyotypic, morphologic and clinical features in patients with acute myeloid blast cells expressing the neural cell adhesion molecule (CD56). Leukemia 1994; 8: 823-826.
10. Lanza F, Bi S, Castoldi G, Goldman JM. Abnormal expression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukemia. Leukemia 1993; 7: 1570-1575.
11. Kern WF, Spier CM, Miller TP, Grogan TM. (CD56)-positive malignant lymphoma. Leuk Lymphoma 1993; 12: 1-10.
12. + immunophenotype of NK progenitors. Leukemia 1996; 10: 923-924.
13. Kojima H, Suzukawa K, Yatabe Y, Hori M, Nagasawa T, Abe T. Establishment of a new natural killer (NK) cell line, TKS-1, from a patient with aggressive type of large granular lymphocyte (LCL) leukemia. Leukemia 1994; 8: 1999-2004.
14. Oshimi K, Yamada O, Kaneko T, Nishinarita S, lizuka Y, Urabe A, Inamori T, Asano S, Takahashi S, Hattori M, Naohara T, Ohira Y, Togawa A, Masuda Y, Okubo Y, Furusawa S, Sakamoto S, Omine M, Mori M, Tatsumi E, Mizoguchi H. Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders. Leukemia 1993; 7: 782-788.
15. Ide GJ, Burg M. Characterization of heparan sulfate proteoglycan that copurifies with the neural cell adhesion molecule. Exp Cell Res 1989; 182: 44-60.
16. Thomas PS, Pietrangeli CE, Hayashi S-I, Schachner M, Goridis C, Low M, Kincade PW. Demonstration of neural cell adhesion molecules on stromal cells that support lymphopoiesis. Leukemia 1988; 2: 171-175.
17. Cunningham BA, Hemperley JJ, Murray B, Prediger EA, Brackenbury R, Edelman GM. Neural cell adhesion molecule: structure, immunoglobulin-like domains, cell surface modulation, and alternative RNA splicing. Science 1987; 236: 799-806.
18. Van Duijnhoven HLP, Helfrich W, De Leij L, Roebroek AJM, Van De Ven WJM, Healey K, Culverwell A, Rossell RJ, Kemshead JT, Patel K. Splicing of the vase exon of neural cell adhesion molecule (NCAM) in human small-cell lung carcinoma (SCLC). Int J Cancer 1992; 50: 118-123.
19. Barton CH, Mann AD, Walsh FS. Characterization of the human N-CAM promoter. Biochem J 1990; 268: 161-168.
20. Pellat-Deceunynck C, Barillé S, Puthier D, Rapp M-J, Harousseau J-L, Bataille R, Amiot M. Adhesion molecules on human myeloma cells: significant changes in expression related to malignancy, tumor spreading, and immortalization. Cancer Res 1995; 55: 3647-3653.
21. Barillé S, Collette M, Bataille R, Amiot M. Myeloma cells upregulate interleukin-6 secretion in osteoblastic cells through cell-to-cell contact but downregulate osteocalcin. Blood 1995; 86: 3151-3159.
22. Miller CH, Carbonell A, Pengs R, Paglieroni T, MacKenzie MR. A human plasma cell line. Cancer 1982; 49: 2019-2096.
23. Karpas A, Fischer P, Swirsky D. Human myeloma cell line carrying a Philadelphia chromosome. Science 1982; 216: 997-999.
24. Katagiri S, Yonezawa T, Kuyama J, Kanayama Y, Nishida K, Abe T, Tamali T, Ohnishi M, Tarui S. Two distinct human myeloma cell lines originating from one patient with myeloma. Int J Cancer 1985; 36: 241-246.
25. Jackson N, Lowe J, Ball J, Bromidge E, Ling NR, Larkins S, Griffith MJ, Franklin IM. Two new lgA1-k plasma cell leukemia cell lines (JJN-1 and JJN-2) which proliferate in response to B cell stimulatory factor 2. Clin Exp Immunol 1989; 75: 93-99.
26. Hamilton MS, Barker HF, Ball J, Drew M, Abbo SD, Franklin IM. Normal and neoplastic human plasma cells express bcl-2 antigen. Leukemia 1991; 5: 768-771.
27. Nilsson K. Characteristics of established myeloma and lymphoblastoid cell lines derived from an E myeloma patient: a comparative study. Int J Cancer 1971; 7: 380-396.
28. Tong AW, Lee J, Wang RM, Dalton WS, Tsuruo T, Fay JW, Stone MJ. Elimination of chemoresistant multiple myeloma clonogenic colony-forming cells by combined treatment with a plasma cell-reactive monoclonal antibody and a P-glycoprotein-reactive monoclonal antibody. Cancer Res 1989; 49: 4829-4834.
29. Diehl V, Schaadt M, Kirchner H, Hellriegel KP, Gudat F, Fonatasch C, Laskewitz E, Guggenheim R. Long-term cultivation of plasma cell leukemia cells and autologous lymphoblasts (LCL) in vitro: a comparative study. Blut 1978; 36: 331-338.
30. Durie BGM, Grogan TM, Spier C, Vela E, Baum V, Rodriquez MA, Frutiger Y. Myelomonocytic myeloma cell line (LB84-1). Blood 1989; 73: 770-776.
31. Grogan TM, Durie BGM, Lomen C, Spier C, Wirt DP, Nagle R, Wilson GS, Richter L, Vela E, Maxey V, McDaniel K, Rangel C. Delineation of a novel pre-B cell component in plasma cell myeloma: immunochemical, immunophenotypic, genotypic, cytologie, cell culture and kinetic features. Blood 1987; 70: 932-942.
32. Pegaro L, Malavasi F, Bellone G, Massaia M, Boccadoro M, Saglio G, Guerrasio A, Benetton G, Lombardi L, Coda R, Avanzi GC. The human myeloma cell line LP-1 : a versatile model in which to study early plasma cell differentiation and c-myc activation. Blood 1989; 73: 1020-1027.
33. Burk KH, Drewinko B, Trujillo JM, Aheran MJ. Establishment of a human plasma cell line in vitro. Cancer Res 1978; 38: 2508-2513.
34. Carney DN, Gazdar AF, Bepler G, Guccion JG, Marangos PJ, Moody TW, Zweig MH, Minna JD. Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res 1985; 45: 2913-2923.
35. Fukuda M, Koeffler HP, Minowada J. Membrane differentiation in human myeloid cells: expression of unique profiles of cell surface glycoproteins in myeloid leukemic cell lines blocked at different stages of differentiation and maturation. Proc Natl Acad Sci USA 1981; 78: 6299-6303.
36. De Waele M, Renmans W, Segers E, De Valck V, Jochmans K, Van Camp B. An immunogold-silver staining method for detection of cell-surface antigens in cell smears. J Histochem Cytochem 1986; 37: 1858-1862.
37. Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Press: Cold Spring Harbor, 1982.
38. Dickson G, Cower HJ, Barton CH, Prentice HM, Elsom VL, Moore SE, Cox RD, Quinn C, Putt W, Walsh FS. Human muscle neural cell adhesion molecule (N-CAM): identification of a muscle-specific sequence in the extracellular domain. Cell 1987; 50: 1119-1130.
39. Hanauer A, Mandel JL. The glyceraldehyde 3 phosphate dehydrogenase gene family: structure of a human cDNA and of an X chromosome linked pseudogene; amazing complexity of the gene family in mouse. EMBO J 1984; 3: 2627-2633.
40. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
41. Turc-Carel C, Philip I, Berger MP, Philip T, Lenoir GM. Chromosome study of Ewing sarcoma cell-lines. Consistency of a reciprocal translocation t(11;22)(q24;q12). Cancer Genet Cytogenet 1984; 12: 1-19.
42. Rettig MB, Ma HJ, Vescio RA, Põld M, Schiller G, Belson D, Savage A, Nishikubo C, Wu C, Fraser J, Said JW, Berenson JR. Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science 1997; 276: 1851-1854.
43. Helfrich MH, Livingston E, Franklin IM, Soutar RL. Expression of adhesion molecules in malignant plasma cells in multiple myeloma: comparison with normal plasma cells and functional significance. Blood Rev 1997; 11: 28-38.
44. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865-1869.